Longeveron LGVN
$ 1.67
4.37%
Quarterly report 2024-Q3
added 11-12-2024
Country |
USA |
IPO year |
2021 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Joshua Michael Hare |
Employees in the company |
16 |
Shares |
21.7 M |
Market Cap[1] |
$ 36.3 M |
EBITDA (LTM) |
$ -16.6 M |
P/E (LTM) |
-0.34 |
P/S (LTM) |
25.11 |
EPS (LTM) |
-6.57 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.